News for Healthier Living
i-Lumen Scientific Announces First U.S. Patient Randomized in i-SIGHT2 Pivotal Study Evaluating Noninvasive Bioelectric Therapy for Intermediate to Advanced Dry AMD
i-Lumen Scientific, Inc., a clinical-stage medical technology company developing bioelectric therapies for retinal disease, today announced the first U.S. patient has been randomized in the i-SIGHT2 pivotal study evaluating the i-Lumen AMD System in patients with intermediate to advanced dry age-related macular degeneration (AMD).
July 21, 2026
July 21 2026July 20 2026July 17 2026July 16 2026July 15 2026July 14 2026July 13 2026July 12 2026July 10 2026 - Rutgers-Led Center Spots Emerging Tobacco Threats Years Faster Than Conventional Surveillance
- Landmark Clinical Trial Results in First FDA-Approved Treatment for Rare Form of Obesity Caused by Brain Injury
- CVD and Collaborators Launch Study to Better Understand Immune Responses to Lassa Fever
- Research Tip Sheet: Cedars-Sinai Heart, Aging and Cancer Advances
- Studying Viral Proteins on a Whole New Scale
- Loss of Radiation Therapy Clinics Could Widen Cancer Care Gaps Across the United States
- Are you a journalist who covers science, health, or environmental issues?
- New Soft Wearable Device Could Support At-Home Sleep Monitoring
- New Research Seeks to Help Transplanted Cells Thrive in Type 1 Diabetes Treatment
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- The Myth of the 'Lizard Brain' and the Real Trade-Off Inside Your Mind
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- AI Can Detect Previously Invisible MS Scars In The Brain
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- JMIR Report: Machine Learning Accelerates Radiopharmaceutical Drug Discovery, Optimizes Personalized Dosimetry
- Among Young Adults, Alcohol-Induced Blackout Are Linked to More Harmful Consequences, With Stronger Associations in Certain Social and Drinking Contexts
- Study Reveals Major Shifts in Alcohol-Related Deaths
- Alcohol Intoxication, Stress in Adolescence Linked with Long-Term Impairments
- Young Adults' Attention to Alcohol Cues in their Environments is Highly Variable and Linked to Their Craving and Drinking, Potentially Informing Interventions
- Insurance Denials for Brand-Name Prescription Drugs Rose Sharply From 2018 to 2024
- Turning Off Cancer-Promoting Signals, Turning On Attack Signals... Anticancer "Nanoswitch" Technology Developed
July 9 2026July 8 2026July 7 2026
|
|
|
|
|